Health Product InfoWatch – October 2021

Monthly recap of health product safety information. The following is a list of health product advisories, type I recalls and summaries of completed safety reviews published in September 2021 by Health Canada.

Publisher - Current Organization Name: Public Health Agency of Canada
Licence: Open Government Licence - Canada

Data and Resources

Health Product InfoWatch – October 2021HTML
English website HTML
Explore
- More information
- Go to resource
Health Product InfoWatch – October 2021HTML
French website HTML
Explore
- More information
- Go to resource
Health Product InfoWatch – October 2021PDF
English website PDF
Explore
- More information
- Go to resource
Health Product InfoWatch – October 2021 (poster)PDF
French website PDF
Explore
- More information
- Go to resource

Similar records

Have your say

Rate this dataset
Provide feedback

Additional Information

Contact Email: open-ouvert@tbs-sct.gc.ca
Keywords:
- pandemic
- COVID-19
- Coronavirus
- COVID
- Health
- Product
- InfoWatch
- October
- 2021
- Pharmaceuticals
- biologics
- CellCept
- (mycophenolate mofetil)
- Gadolinium-based
- contrast agents
- Glucagon
- Losartan
- Lumakras (sotorasib)
- Mirvala 28
- Pemazyre (pemigatinib)
- Truseltiq (infigratinib)
- Zepzelca (lurbinectedin)
- Zyloprim (allopurinol)
- Coronavirus disease
- (COVID-19)
- Monthly recap
- New information
- Vaccine
- safety
- biannual
- summary
- January 1
- 2020
- June 30
- 2020
- Product monograph
- update
- CellCept
- (mycophenolate mofetil)
- Zyloprim
- (allopurinol)
- Lumakras
- (sotorasib)
- Pemazyre
- (pemigatinib)
- Truseltiq
- (infigratinib)
- Notice
- market
- authorization
- conditions
- Zepzelca
- (lurbinectedin)
- Scope
- Reporting
- Adverse
- Reactions
Subject:
- Health and Safety
Maintenance and Update Frequency: Monthly
Date Published: 2021-10-28

About this Record

Record Released: 2021-11-08
Record Modified: 2021-11-08
Record ID: 0ccedc75-8239-47d2-9642-a466c729c629
Metadata:
Atom Feed